Close Menu
Business News MEA
    Facebook X (Twitter) Instagram
    Monday, September 14
    Facebook X (Twitter) Instagram LinkedIn VKontakte
    Business News MEABusiness News MEA
    • Home
    • UAE
    • Business
    • Technology
    • Lifestyle
    • Sports
    Business News MEA
    You are at:Home»UAE»SAKINA explores advanced brain stimulation research in collaboration with PeakLogic
    UAE

    SAKINA explores advanced brain stimulation research in collaboration with PeakLogic

    Editorial TeamBy Editorial TeamSeptember 14, 2026
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    ABU DHABI, 14th September, 2026 (WAM) — SAKINA, the leading mental health network under SEHA, a subsidiary of PureHealth, has signed a strategic Memorandum of Understanding with US-based medical technology company PeakLogic to explore advanced neuroscience approaches that support the diagnosis and treatment of mental and brain health conditions.

    Under the MoU, the parties will collaborate on clinical research studies to assess the efficacy of Personalised Repetitive Transcranial Magnetic Stimulation (PrTMS®), alongside PeakLogic’s spectral Electroencephalogram analysis (sEEG) capabilities.

    The research will focus on a range of conditions, including Autism SpectrumDisorder (ASD), Traumatic Brain Injury (TBI), concussion and Major Depressive Disorder (MDD).

    The collaboration also includes the use of PeakLogic’s sEEG and specialised training for relevant teams on PeakLogic’s platforms and tools, supporting knowledge exchange and the development of evidence-based practice.

    Dr. Zain Ali Al Yafai, Chief Executive Officer of SAKINA, said, “Our partnership with PeakLogic reinforces our commitment to bringing the latest neuroscience innovations to the UAE. Through clinically governed research into advanced magnetic stimulation and data-driven assessment, we aim to support more precise, personalised care for individuals living with complex neuropsychiatric conditions.”

    Kevin T. Murphy, MD, Founder and Chief Executive Officer of PeakLogic Inc., stated, “PeakLogic is thrilled to partner with SAKINA to explore the application of our PrTMS® therapeutic approach in supporting individuals with autism. We look forward to working alongside a dedicated team of experts who share our commitment to expanding access to innovative, personalised care and improving the lives of patients across the UAE and beyond.”

    SAKINA currently provides Transcranial Magnetic Stimulation (TMS) as part of its mental health services. TMS is a non-invasive, non-pharmacological treatment option that can be used for patients who do not respond to medication, providing an established clinical foundation to support this collaboration.

    Source: Emirates News Agency

    Previous ArticleUAE President issues Federal Decree appointing Secretary-General of UAE Council for Fatwa
    Next Article Space42, Viasat sign binding agreement to co-found ‘Equatys’

    Related Posts

    UAE Team Emirates-XRG claims double success in Canada, Italy

    September 14, 2026

    UAE President issues Federal Decree appointing Secretary-General of UAE Council for Fatwa

    September 14, 2026

    Hamdan bin Mohammed chairs Supervisory Committee of Mohammed bin Rashid Leadership Medal, approves first recipient

    September 14, 2026
    Don't Miss

    UAE Team Emirates-XRG claims double success in Canada, Italy

    India coach stands by team after refusal to collect Asia cup trophy from Naqvi

    Space42, Viasat sign binding agreement to co-found ‘Equatys’

    SAKINA explores advanced brain stimulation research in collaboration with PeakLogic

    2026. All rights reserved.
    • Home
    • UAE
    • Business
    • Technology
    • Lifestyle
    • Sports
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.